Derma Sciences (NASDAQ: DSCI) reported Q3 EPS of ($0.35), $0.08 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $22.31 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.